| Unique ID issued by UMIN | UMIN000041383 |
|---|---|
| Receipt number | R000047241 |
| Scientific Title | Multicenter study of brain imaging-fluid biomarker correlation in neuropsychiatric disorders |
| Date of disclosure of the study information | 2020/08/11 |
| Last modified on | 2020/08/11 08:02:56 |
Multicenter study of brain imaging-fluid biomarker correlation in neuropsychiatric disorders
Brain imaging-fluid biomarker correlation in neuropsychiatric disorders
Multicenter study of brain imaging-fluid biomarker correlation in neuropsychiatric disorders
Brain imaging-fluid biomarker correlation in neuropsychiatric disorders
| Japan |
Alzheimer's disease and other psychiatric and neurological disorders underlying the accumulation of abnormal proteins such as tau protein
| Neurology | Psychiatry |
Others
NO
to explore the relevance of brain imaging findings/ fluid biomarkers to clinical information., fluid biomarkers to clinical information, and fluid biomarkers to brain imaging findings
Others
to explore the relevance of brain imaging findings and fluid biomarkers
the association among tau/amyloid PET tracer, brain atrophy/function, fluid biomarkers and clinical information
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
2
Diagnosis
| Medicine |
[11C]PiB: approx. 370MBq (10mCi)
18F]PM-PBB3: approx. 185MBq (5mCi)
PET scan,
MRI scan
Neuropsychological testing, and
up to 10 ml of blood and CSF examinations
[11C]PiB: approx. 370MBq (10mCi)
18F]PM-PBB3: approx. 185MBq (5mCi)
PET scan,
MRI scan
Neuropsychological testing, and
up to 10 ml of blood and CSF examinations
| 20 | years-old | <= |
| Not applicable |
Male and Female
Those who meet the diagnostic criteria for psychiatric and neurological disorders, such as Alzheimer's disease, where the accumulation of abnormal proteins, such as tau protein, has been suggested to be involved in the disorder.
(1) Patients with complications or those with a history of such complications and who are judged by the researcher or other physicians to be inappropriate for the study.
(2) Patients with severe claustrophobia.
(3) The person who is pregnant or may be pregnant and the person who is breastfeeding.
(4) In the case of PET examination in this study, in consideration of exposure in nuclear medicine examination, the subject must be within 6 months from the time of participation in other studies involving radiation exposure.
(5) Other persons who are judged by the physician to be unsuitable as research subjects.
460
| 1st name | Makoto |
| Middle name | |
| Last name | Higuchi |
National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology
Department of Functional Brain Imaging Research
263-8555
4-9-1 Anakawa, Inage-ku, Chiba City, Chiba
043-251-2111
higuchi.makoto@qst.go.jp
| 1st name | Kenji |
| Middle name | |
| Last name | Tagai |
National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Scienc
Department of Functional Brain Imaging Research
263-8555
4-9-1 Anakawa, Inage-ku, Chiba City, Chiba
043-251-2111
tagai.kenji@qst.go.jp
National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science
National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science
Other
Certified Review Board
4-9-1 Anagawa, Inage-ku, Chiba
043-206-4709
helsinki@qst.go.jp
NO
1
| 2020 | Year | 08 | Month | 11 | Day |
Unpublished
Enrolling by invitation
| 2020 | Year | 06 | Month | 29 | Day |
| 2020 | Year | 08 | Month | 03 | Day |
| 2020 | Year | 08 | Month | 18 | Day |
| 2025 | Year | 03 | Month | 31 | Day |
| 2020 | Year | 08 | Month | 11 | Day |
| 2020 | Year | 08 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047241